Megna Michael R
Reporting owner on Forms 3, 4 and 5, CIK 1464583.
Megna Michael R reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-12.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| KNSA · Kiniksa Pharmaceuticals International, plcCIK 1730430 | officer (CHIEF ACCOUNTING OFFICER) | 2 | 2026-11-12 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-09 | M exercised | +11,280 | $17.76 | 23,977 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-09 | S sold | -11,280 | $98.54 | 12,697 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-11-09 | M exercised | -11,280 | $0 | 5,114 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | M exercised | +4,689 | $10.76 | 33,751 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | M exercised | +3,932 | $11.1 | 37,683 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | M exercised | +7,209 | $11.97 | 44,892 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | M exercised | +4,065 | $17.76 | 48,957 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -6,030 | $91.87 | 42,927 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -6,831 | $92.77 | 36,096 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -9,508 | $94.2 | 26,588 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -3,705 | $94.86 | 22,883 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -3,145 | $96.08 | 19,738 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -1,691 | $97.11 | 18,047 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -5,350 | $97.74 | 12,697 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-10-30 | M exercised | -3,932 | $0 | 0 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-10-30 | M exercised | -7,209 | $0 | 0 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-10-30 | M exercised | -4,689 | $0 | 2,983 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-10-30 | M exercised | -4,065 | $0 | 16,394 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001464583-26-000012 | Kiniksa Pharmaceuticals International, plc | 2026-11-12 | ||
| Form 4 0001464583-26-000010 | Kiniksa Pharmaceuticals International, plc | 2026-11-03 |